Thus, the in vitro cell study showed that e-liquid activates EGFR signaling and influences the growth of brain tumor cells via pERK activation while animal xenograft study showed that e-liquid promotes accelerated cancer growth which leads to poor prognosis. Here, EIF2AK3 is linked to cancer.